Aaryan Biocare Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 673.78%
- Profit Growth 306.22%
- Ebitda 170.51%
- Net Worth 253.54%
- Total Assets 160.64%
About Aaryan Biocare Products
Aaryan Biocare Products Private Limited (ABPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2022 (Three years and one month 21 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yuvraj Kalwale and Radha Kalwale serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290PN2022PTC207357
- Company No.
207357
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Aaryan Biocare Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yuvraj Kalwale  | Director | 03-Jan-2022 | Current |
| Radha Kalwale | Director | 03-Jan-2022 | Current |
Financial Performance of Aaryan Biocare Products.
Aaryan Biocare Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 673.78% increase. The company also saw a substantial improvement in profitability, with a 306.22% increase in profit. The company's net worth Soared by an impressive increase of 253.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aaryan Biocare Products?
Unlock access to Aaryan Biocare Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aaryan Biocare Products?
Aaryan Biocare Products has a workforce of 15 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aaryan Biocare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aaryan Biocare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.